S. Quétant

1.1k total citations · 1 hit paper
19 papers, 536 citations indexed

About

S. Quétant is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Epidemiology. According to data from OpenAlex, S. Quétant has authored 19 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 5 papers in Surgery and 4 papers in Epidemiology. Recurrent topics in S. Quétant's work include Cystic Fibrosis Research Advances (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Transplantation: Methods and Outcomes (5 papers). S. Quétant is often cited by papers focused on Cystic Fibrosis Research Advances (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Transplantation: Methods and Outcomes (5 papers). S. Quétant collaborates with scholars based in France, United States and Netherlands. S. Quétant's co-authors include Laurent Mély, Martine Reynaud‐Gaubert, I. Durieu, Dominique Grenet, R. Chiron, Lydie Lemonnier, Jennifer Da Silva, Christophe Marguet, Jean-Louis Paillasseur and Pierre‐Régis Burgel and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Scientific Reports and CHEST Journal.

In The Last Decade

S. Quétant

16 papers receiving 527 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease

2021 148 citations Pierre‐Régis Burgel, I. Durieu et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers

Countries citing papers authored by S. Quétant

Since Specialization

Citations

This map shows the geographic impact of S. Quétant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Quétant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Quétant more than expected).

Fields of papers citing papers by S. Quétant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Quétant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Quétant. The network helps show where S. Quétant may publish in the future.

Co-authorship network of co-authors of S. Quétant

This figure shows the co-authorship network connecting the top 25 collaborators of S. Quétant. A scholar is included among the top collaborators of S. Quétant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Quétant. S. Quétant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease breakdown → 2021 ·American Journal of Respiratory and Critical Care Medicine ·Pierre‐Régis Burgel, I. Durieu, R. Chiron, Sophie Ramel, Isabelle Danner‐Boucher, Anne Prévötat, Dominique Grenet, Christophe Marguet, Martine Reynaud‐Gaubert, Julie Macey, Laurent Mély, Annlyse Fanton, S. Quétant, Lydie Lemonnier, Jean-Louis Paillasseur, Jennifer Da Silva, Clémence Martin	148
2	Airway complications in lung transplant recipients with telomere‐related interstitial lung disease 2021 ·Clinical Transplantation ·Bina Choi, Jonathan Messika, Andrew Courtwright, Jean François Mornex, Sandrine Hirschi, Antoine Roux, Jérôme Le Pavec, S. Quétant, Antoine Froidure, Romain Lazor, Martine Reynaud‐Gaubert, (unknown), (unknown), Hilary J. Goldberg, Souheil El‐Chemaly, Raphaël Borie, (unknown)	10
3	Rheological analysis of sputum from patients with chronic bronchial diseases 2020 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), (unknown), B. Camara, S. Quétant, Jean‐Luc Cracowski, Claire Cracowski, Matthieu Robert de Saint Vincent	45
4	Sélection des candidats à la transplantation pulmonaire en France en 2019 2019 ·Revue des Maladies Respiratoires ·(unknown), (unknown), (unknown), S. Quétant, (unknown), Amandine Briault, Pierluigi Porcu, (unknown), (unknown), Christophe Pison, Johanna Claustre	3
5	Effets d’un accompagnement en activités physiques adaptées (APA) supervisé à domicile chez des patients atteints de mucoviscidose 2018 ·Science & Sports ·(unknown), (unknown), Sébastien Chanoine, S. Quétant, (unknown), (unknown), (unknown), Isabelle Pin, Bernard Wuyam, (unknown)	1
6	Favorable Evolution of Cryptococcal Meningitis in the Context of Flucytosine Resistance. 2018 ·Experimental and Clinical Transplantation ·Johanna Claustre, (unknown), S. Quétant, Pierrick Bedouch, (unknown), (unknown)	0
7	WS08.6 Effects of home-based adapted physical activity in patients with cystic fibrosis: an interventional study 2018 ·Journal of Cystic Fibrosis ·(unknown), Andreas Fuchs, José Carlos Benítez, S. Quétant, Sébastien Chanoine, (unknown), (unknown), Bernard Wuyam, (unknown), Isabelle Pin	1
8	Glucose trajectories in cystic fibrosis and their association with pulmonary function 2017 ·Journal of Cystic Fibrosis ·Quitterie Reynaud, Muriel Rabilloud, Sylvain Roche, (unknown), Jean Iwaz, R. Nové-Josserand, Emilie Blond, Martine Laville, (unknown), S. Quétant, Philippe Reix, Sandrine Touzet, I. Durieu	12
9	DI-087 Restrictive allograft syndrome in lung transplantation: nintedanib as a new therapeutic strategy? 2017 ·(unknown), Sébastien Chanoine, (unknown), Amandine Briault, S. Quétant, Christophe Pison, Pierrick Bedouch	2
10	DI-086 Interstitial lung disease induced by infliximab: a case report 2017 ·(unknown), Sébastien Chanoine, (unknown), S. Quétant, Christophe Pison, Pierrick Bedouch	0
11	Absence of calf muscle metabolism alterations in active cystic fibrosis adults with mild to moderate lung disease 2016 ·Journal of Cystic Fibrosis ·Nicolas Decorte, Mathieu Gruet, B. Camara, S. Quétant, Laurent Mély, Jean‐Marc Vallier, Samuel Vergès, Bernard Wuyam	12
12	Intensité des soins lors des exacerbations et des complications des pathologies respiratoires chroniques 2016 ·Revue des Maladies Respiratoires ·(unknown), (unknown), S. Quétant, Christophe Pison, (unknown), (unknown), (unknown), (unknown), Maïté Garrouste-Orgeas, (unknown), Nicolas Terzi, (unknown)	0
13	Skeletal muscle contractility and fatigability in adults with cystic fibrosis 2015 ·Journal of Cystic Fibrosis ·Mathieu Gruet, Nicolas Decorte, Laurent Mély, Jean‐Marc Vallier, (unknown), S. Quétant, Bernard Wuyam, Samuel Vergès	40
14	Nonspecific Immunoglobulin Replacement in Lung Transplantation Recipients With Hypogammaglobulinemia 2014 ·Transplantation ·Johanna Claustre, S. Quétant, (unknown), (unknown), (unknown), Pierrick Bedouch, Patricia Pavèse, (unknown), (unknown), Dominique Masson, Hubert Roth, Christophe Pison	10
15	Development of a pharmacist collaborative care program for pulmonary arterial hypertension 2011 ·International Journal of Clinical Pharmacy ·Pierrick Bedouch, Matthieu Roustit, S. Quétant, Claire Chapuis, (unknown), Audrey Lehmann, (unknown), Christophe Pison, Benoît Allenet	5
16	Use of Intensive Care in Patients With Nonresectable Lung Cancer 2010 ·CHEST Journal ·Anne‐Claire Toffart, Clémence Minet, Bruno Raynard, Carole Schwebel, Rébecca Hamidfar-Roy, (unknown), S. Quétant, Denis Moro‐Sibilot, Élie Azoulay, Jean‐François Timsit	59
17	Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases 2010 ·Lara D. Veeken ·Athan Baillet, Candice Trocmé, Sylvie Berthier, Marie Arlotto, (unknown), Jérôme Chenau, S. Quétant, Michel Sève, François Berger, Robert Juvin, Françoise Morel, Philippe Gaudin	99
18	Lung Transplantation for Lymphangioleiomyomatosis: The French Experience 2008 ·Transplantation ·Martine Reynaud‐Gaubert, Jean‐François Mornex, Hervé Mal, M. Treilhaud, Claire Dromer, S. Quétant, François Leroy-Ladurie, R. Guillemain, F. Philit, Gaëlle Dauriat, D. Grenet, M. Stern	53
19	Unusual cystic presentation of pulmonary nodular amyloidosis associated with MALT-type lymphoma 2007 ·European Respiratory Journal ·Sylvie Lantuéjoul, (unknown), S. Quétant, (unknown), C Brambilla, E Brambilla, G. Ferretti	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact